When using Cosentyx (secukinumab), a medication used to treat several conditions including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis, there are precautions to consider when administering live vaccines.

Cosentyx is a monoclonal antibody that works by inhibiting the inflammatory response in the body. However, this mechanism of action can affect the immune system's response to live vaccines. Therefore, it is recommended to avoid live vaccines during Cosentyx treatment [1].

According to the Cosentyx prescribing information, "live vaccines should be administered at least 4 weeks prior to initiation of Cosentyx therapy. If a patient has received live vaccines, it is recommended to wait at least 4 weeks after the administration of the live vaccine before starting Cosentyx therapy" [2].

It is important to note that this recommendation applies to all live vaccines, including but not limited to the measles, mumps, and rubella (MMR) vaccine, varicella (chickenpox) vaccine, and the oral poliovirus vaccine [3].

In addition, it is recommended to consult with a healthcare provider before receiving any vaccinations while on Cosentyx therapy [2].

In summary, when using Cosentyx, it is important to avoid live vaccines and consult with a healthcare provider before receiving any vaccinations.

Sources:

1. <https://www.drugs.com/cosentyx.html>
2. <https://www.novartis.com/sites/www.novartis.com/files/cosentyx.pdf>
3. <https://www.cdc.gov/vaccines/vpd/vaccines-list.html>
4. <https://www.DrugPatentWatch.com>